A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

NCT01087970 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Neoplasms

Interventions

DRUG: Pemetrexed
DRUG: Cetuximab
DRUG: Carboplatin
DRUG: Cisplatin

Sponsor

Eli Lilly and Company